High Times – by Maureen Meehan
At the turn of the century, before the Marihuana Tax Act of 1937, Eli Lilly, Parke-Davis and Squibb of Bristol-Myers Squibb, were marketing cannabis extracts and tinctures labeled as “uniformly effective at dose levels of 10 mg.”
In those days, most medicines had the same generic characteristics, so drug companies had to rely on marketing and brand recognition to sell their products. Continue reading “Big Pharma Companies Were The Original Medical Pot Sellers”

Freedom Outpost – by Michael Bastasch
ABC 6
The Daily Sheeple – by Melissa Melton
American Everyman – by Scott Creighton
BBC
Roll Call – by Bridget Bowman and Emma Dumain
Food Safety News
Western Journalism – by B. CHRISTOPHER AGEE
Yahoo News – by PIERRE THOMAS and MIKE LEVINE
Ben Swann – by Annabelle Bamforth
Veterans Today – by Preston James, PhD
The Free Thought Project – by Matt Agorist
Gun Watch – by Dean Weingarten
Pirate’s Cove
ABC News – by BEN CANDEA
RT